Search by Drug Name or NDC
NDC 00409-1761-10 Marcaine Spinal 7.5 mg/mL Details
Marcaine Spinal 7.5 mg/mL
Marcaine Spinal is a SUBARACHNOID INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUPIVACAINE HYDROCHLORIDE.
Product Information
| NDC | 00409-1761 |
|---|---|
| Product ID | 0409-1761_f16150a3-6fc7-443f-909c-688fdd99b1ab |
| Associated GPIs | 69100010112010 |
| GCN Sequence Number | 052199 |
| GCN Sequence Number Description | bupivacaine HCl in dextrose/PF AMPUL 0.75 % INJECTION |
| HIC3 | H0A |
| HIC3 Description | LOCAL ANESTHETICS |
| GCN | 19768 |
| HICL Sequence Number | 025245 |
| HICL Sequence Number Description | BUPIVACAINE HCL IN DEXTROSE/PF |
| Brand/Generic | Brand |
| Proprietary Name | Marcaine Spinal |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bupivacaine Hydrochloride in Dextrose |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBARACHNOID |
| Active Ingredient Strength | 7.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | BUPIVACAINE HYDROCHLORIDE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018692 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-1761-10 (00409176110)
| NDC Package Code | 0409-1761-10 |
|---|---|
| Billing NDC | 00409176110 |
| Package | 2 CELLO PACK in 1 CARTON (0409-1761-10) / 5 AMPULE in 1 CELLO PACK (0409-1761-05) / 2 mL in 1 AMPULE (0409-1761-18) |
| Marketing Start Date | 2022-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |